- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.86 Å
- Oligo State
- homo-tetramer
- Ligands
- 10 x MG: MAGNESIUM ION(Non-covalent)
- 4 x YPG: [3-[(3~{R},4~{R})-3-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-[(2~{S})-2-oxidanyl-2-phosphono-ethoxy]pyrrolidin-1-y l]-3-oxidanylidene-propyl]phosphonic acid(Non-covalent)
YPG.3: 20 residues within 4Å:- Chain A: K.82, G.83, R.117, E.149, I.151, I.152, D.153, T.154, G.155, K.156, T.157, K.181, A.201, F.202, V.203, L.208, D.209, R.215
- Ligands: MG.1, MG.2
20 PLIP interactions:20 interactions with chain A- Hydrogen bonds: A:K.82, A:G.83, A:R.117, A:R.117, A:E.149, A:D.153, A:T.154, A:T.154, A:T.154, A:T.154, A:G.155, A:K.156, A:T.157, A:T.157, A:T.157, A:V.203, A:V.203, A:V.203, A:R.215, A:R.215
YPG.6: 20 residues within 4Å:- Chain B: K.82, G.83, R.117, E.149, I.151, I.152, D.153, T.154, G.155, K.156, T.157, K.181, A.201, F.202, V.203, L.208, D.209, R.215
- Ligands: MG.4, MG.5
19 PLIP interactions:19 interactions with chain B- Hydrogen bonds: B:L.81, B:K.82, B:G.83, B:D.153, B:T.154, B:T.154, B:T.154, B:T.154, B:G.155, B:K.156, B:T.157, B:T.157, B:T.157, B:V.203, B:V.203, B:V.203, B:D.209, B:R.215, B:R.215
YPG.10: 22 residues within 4Å:- Chain C: L.81, K.82, G.83, R.117, E.149, D.150, I.151, D.153, T.154, G.155, K.156, T.157, L.158, K.181, A.201, F.202, V.203, L.208, D.209, R.215
- Ligands: MG.7, MG.8
21 PLIP interactions:21 interactions with chain C- Hydrogen bonds: C:L.81, C:K.82, C:G.83, C:R.117, C:R.117, C:D.153, C:T.154, C:T.154, C:T.154, C:G.155, C:K.156, C:T.157, C:T.157, C:T.157, C:V.203, C:V.203, C:V.203, C:D.209, C:R.215, C:R.215
- pi-Cation interactions: C:F.202
YPG.14: 22 residues within 4Å:- Chain D: L.81, K.82, G.83, R.117, E.149, I.151, I.152, D.153, T.154, G.155, K.156, T.157, L.158, K.181, A.201, F.202, V.203, L.208, D.209, R.215
- Ligands: MG.11, MG.12
19 PLIP interactions:19 interactions with chain D- Hydrogen bonds: D:L.81, D:K.82, D:G.83, D:D.153, D:D.153, D:T.154, D:T.154, D:T.154, D:T.154, D:G.155, D:K.156, D:T.157, D:T.157, D:T.157, D:V.203, D:V.203, D:V.203, D:R.215, D:R.215
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Keough, D.T. et al., Design of Plasmodium vivax Hypoxanthine-Guanine Phosphoribosyltransferase Inhibitors as Potential Antimalarial Therapeutics. ACS Chem. Biol. (2018)
- Release Date
- 2017-12-13
- Peptides
- Hypoxanthine phosphoribosyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
HC
KD
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.86 Å
- Oligo State
- homo-tetramer
- Ligands
- 10 x MG: MAGNESIUM ION(Non-covalent)
- 4 x YPG: [3-[(3~{R},4~{R})-3-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-[(2~{S})-2-oxidanyl-2-phosphono-ethoxy]pyrrolidin-1-y l]-3-oxidanylidene-propyl]phosphonic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Keough, D.T. et al., Design of Plasmodium vivax Hypoxanthine-Guanine Phosphoribosyltransferase Inhibitors as Potential Antimalarial Therapeutics. ACS Chem. Biol. (2018)
- Release Date
- 2017-12-13
- Peptides
- Hypoxanthine phosphoribosyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
HC
KD
L